Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
批准号:
10407469
负责人:
XIAOXIN Luke CHEN
金额:
$16.92万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-01 至 2022-12-31
关键词:
3-DimensionalAffectAnabolismAnimal ModelApoptosisArchitectureAutomobile DrivingBiochemistryBiological ModelsBiologyCDKN2A geneCUL3 geneCancer EtiologyCell LineCell modelCellsCellular biologyCessation of lifeClinicDataData SetDevelopmentDiagnosisDrug Metabolic DetoxicationDrug ScreeningEpithelialEpithelial CellsEsophageal Squamous Cell CarcinomaEsophagusEventExperimental ModelsExpression ProfilingFutureGenesGeneticGenetic TranscriptionGrowthHumanHyperactivityHyperplasiaIn VitroLesionLongevityLoxP-flanked alleleLungMalignant Epithelial CellMalignant NeoplasmsMalignant neoplasm of lungMetabolismModelingMolecularMusMutateMutationNeoplasm MetastasisNormal CellOncogenicOrganoidsPI3K/AKTPIK3CA genePathway interactionsPatientsPharmacologyPharmacology StudyPhasePhenotypePhosphotransferasesPreventiveProteomicsPyrimethaminePyruvate KinaseRecurrenceRegulationReportingResearchSignal PathwaySignal TransductionStainsStressSurveysSurvival RateTP53 geneTamoxifenTestingTherapeuticTherapeutic AgentsTissue MicroarrayTissuesTranslatingTumor PromotersUnited StatesValidationWorkXenograft procedureadvanced diseasecancer typedesigndifferential expressionexperimental studygenomic locusin vivoinhibitorinsightmembermetabolomicsmolecular phenotypemultiple omicsnew therapeutic targetnovelnovel therapeuticsresponsesmall moleculesmall molecule inhibitortargeted treatmenttherapeutic evaluationtranscription factortranscriptome sequencingtumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This multiple-PI R01 proposal is designed to incorporate genetic and pharmacological approaches to
understand the mechanisms of NRF2 hyperactivation in ESCC and to develop targeted therapy for Nrf2high
ESCC. We believe Nrf2 and kinases are functionally interrelated, and thus cooperatively contribute to ESCC.
In this proposal, we aim to characterize the molecular and phenotypic consequences of NRF2 hyperactivation
in ESCC, determine the mechanisms of action and efficacy of NRF2 small molecule inhibitors in ESCC, and
identify NRF2-responsive kinases and their functions in NRF2-driven ESCC biology. Through three
independent yet tightly related Specific Aims, we will provide novel insights into pathway regulation and novel
therapeutic targets/agents for NRF2high ESCC. If proven effective, some compounds may be further translated
into the clinic for targeted therapy of NRF2high ESCC in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology
-
批准号:10810414
-
项目类别:
-
资助金额:$57.33万
-
财政年份:2022
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology
-
批准号:10673201
-
项目类别:
-
资助金额:$61.69万
-
财政年份:2022
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
-
批准号:10530998
-
项目类别:
-
资助金额:$8.34万
-
财政年份:2020
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
-
批准号:10851493
-
项目类别:
-
资助金额:$8.12万
-
财政年份:2020
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
-
批准号:10850620
-
项目类别:
-
资助金额:$39.74万
-
财政年份:2020
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
NOTCH-PAX9 signaling in alcohol-induced esophageal injury
-
批准号:10023247
-
项目类别:
-
资助金额:$21.28万
-
财政年份:2019
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Research Infrastructure Core (RIC)
-
批准号:9977710
-
项目类别:
-
资助金额:$87.75万
-
财政年份:2017
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Research Infrastructure Core (RIC)
-
批准号:10204733
-
项目类别:
-
资助金额:$75.05万
-
财政年份:2017
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Pilot Project 2: Nrf2 Activation in Esophageal Squamous Cell Carcinogenesis In Vivo
-
批准号:9050352
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2010
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Resource/Infrastructure Development Core
-
批准号:8068492
-
项目类别:
-
资助金额:$4.71万
-
财政年份:2010
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Histopathology Core-Shared Resources
-
批准号:10247142
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2010
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Racial Disparity in Barrett's Esophagus
-
批准号:8068482
-
项目类别:
-
资助金额:$35.81万
-
财政年份:2010
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Oxidative Stress in Alcohol-associated Oral Carcinogenesis
-
批准号:8123736
-
项目类别:
-
资助金额:$3.66万
-
财政年份:2010
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Full Project 5: Mechanisms and Targeted Therapy of Nrf2high Esophageal Squamous Cell Carcinoma
-
批准号:10247148
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2010
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Chemoprevention of Tobacco-related Oral Carcinogenesis
-
批准号:6640968
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2003
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Chemoprevention of Tobacco-related Oral Carcinogenesis
-
批准号:7116117
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2003
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Chemoprevention of Tobacco-related Oral Carcinogenesis
-
批准号:6744836
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2003
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Chemoprevention of Tobacco-related Oral Carcinogenesis
-
批准号:6880067
-
项目类别:
-
资助金额:$8.56万
-
财政年份:2003
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Animal Model of Barrett's Esophagus
-
批准号:6665456
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2002
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Animal Model of Barrett's Esophagus
-
批准号:6578385
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2002
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
海外基金